BEGIN:VCALENDAR VERSION:2.0 PRODID:icalendar-ruby CALSCALE:GREGORIAN BEGIN:VEVENT DTSTAMP:20240329T061321Z UID:b3abf0bf-5e05-4e91-9100-aae98fc63f92 DTSTART:20220316T073000 DTEND:20220318T160000 CLASS:PRIVATE DESCRIPTION:
\nThe
8th Annual Immuno-Oncology 360°\; Delivers Three Key Benefits:
\n<
br />\n- Access to KOLs driving the science
\n- Partnership opportuni
ties with all stakeholders in Immuno-Oncology
\n- Presentations on th
e latest data impacting the science\, clinical and business advancements i
n Immuno-Oncology
\n
\n2022 Key Topic Areas
\n- Discovery/P
reclinical Science
\n- Cell and Gene Therapy
\n- Translational S
cience
\n- Bispecifics
\n- Clinical Developments
\n- Neoadj
uvant/Adjuvant Data
\n- Emerging Biomarkers
\n- Cytokines
\
n- Clinical Operations
\n- IO Combinations
\n- Imaging Advanceme
nts
\n- Business Developments
\n
\nImmuno-Oncology 360°\
; reports on the most current data and rapid advancements to help IO stake
holders:
\n- Be at the forefront of the most relevant research and de
velopments from key leadership who are at the pulse of cancer immunotherap
y
\n- Foster collaboration amongst those working in all aspects of ca
ncer immunotherapy together under one roof
\n- Partner to expand tech
nology platforms to develop therapeutics at an accelerated rate
\n- R
eceive the latest pre-clinical\, translational and clinical data from acad
emia and industry
\n- Create and prioritize strategies targeted towar
d specific tumor types
\n- Identify and gain a greater understanding
of what assets are available for potential combinations
\n- Hear from
IO clinical trial leaders as they cover trial design\, clinical operation
s\, the latest outcomes and lessons learned
\n- Get key investor and
analyst evaluations and insights on the IO landscape\, challenges and what
'\;s next
\n- Learn about biomarker advancements in vaccines\, ima
ging\, neoantigen approaches and more
\n- Obtain coverage on a wide r
ange of emerging technologies
\n
\nURLs:
\
nTickets: https://go.evvnt.com/976663-2?pid=
4528
\nSponsor: https://go.evvnt.co
m/976663-3?pid=4528
\nBrochure: htt
ps://go.evvnt.com/976663-4?pid=4528